Home

News 1918 views 1 comment

Steps taken towards new coccidiosis vaccine

Researchers funded by the Biotechnology and Biological Sciences Research Council (BBSRC), among others, have taken the first step in developing a new type of vaccine to protect chickens against coccidiosis, the most important parasite of poultry globally.

A vaccine of this type - based on proteins from the coccidiosis bug rather than being derived from a live parasite - could be produced on a larger scale than is currently possible so could be used to provide much more widespread protection to chicken flocks.

Coccidiosis-causing-parasite
The researchers produced a much more detailed picture of how coccidiosis attacks chickens, uncovering the protein molecules which are secreted onto the surface of the coccidiosis-causing-parasite, Eimeria, that allow it to attach-to and invade cells in a chicken's gut. The scientists also found that when purified and used to inoculate chickens, one of these molecules provided the birds with some protection against coccidiosis and so shows promise as the basis of a new vaccine.

The research was carried out by an international team with funding from BBSRC, the Engineering and Physical Sciences Research Council (EPSRC), the Medical Research Council (MRC) and the Wellcome Trust. The research is published today (13 October) in the journal PLoS Pathogens and the UK-based research took place at Imperial College London, the Institute for Animal Health, the University of Oxford and the Royal Veterinary College.

Cost of coccidiosis
Professor Fiona Tomley of the Royal Veterinary College said "Coccidiosis is the most important parasite of poultry globally. Conservative estimates by the EU put the annual worldwide cost of coccidiosis at over £1billion so controlling it is very important economically but it is also valuable for improving the health and welfare of chickens."

Currently, coccidiosis is treated with antimicrobial drugs or using a vaccine derived from a live parasite. Both of these methods are problematic as drug resistance is widespread and the vaccine is relatively expensive to produce so cannot be used on a wide, preventative scale. Vaccines for some other diseases are based on single proteins rather than killed versions of the disease-causing bug. These so-called 'recombinant vaccines' offer a number of advantages over killed-disease vaccines as they are safer and can be produced more cheaply and quickly and on an industrial scale.

Related websites:
Imperial College London
The Institute for Animal Health
BBSRC

Photo source: Professor DJP Ferguson, University of Oxford

Editor WorldPoultry

One comment

  • no-profile-image

    Ken Marshall

    Scarcely a week passes and news of another improved chicken "Life saving" product, will in time, make its way onto the market. With Coccidiosis being one of the top ranked 'Cost Eaters' of profits of chickens 'on the floor' This will be good news for many!

Or register to be able to comment.